Next AdvaMed Chief Is BIO Exec Scott Whitaker
This article was originally published in The Gray Sheet
Executive Summary
Whitaker, appointed as the next CEO of AdvaMed, currently runs day-to-day operations at the Biotechnology Innovation Organization and has held high-level posts at HHS. Among his accomplishments, Whitaker led the legislative office at HHS when the first device user fee bill was passed in 2002.